Lexaria Bioscience Corp (LEXX): Rasio rega marang pendapatan

Simbol lan logo merek Lexaria Bioscience (LEXX)

Lexaria Bioscience (LEXX) is recognized as a leading innovator due to its DehydraTECH system, as confirmed by this chart. Fluctuations in the P/S multiple demonstrate market sentiment, while the 46.80 indicator reflects current dynamics. The business model relies on royalties from global partners, ensuring seamless scalability. However, the volatility of licensing payments and competition from tech giants create certain risks for the company's sustainability.

LEXX Kapitalisasi marang pendapatan Lexaria (04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Lexaria Bioscience (LEXX)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega lexariabioscience.com|LEXX - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar Lexaria|LEXX - Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Aset Bersih saben Saham Lexaria Bioscience|LEXX - Aset Bersih Perusahaan|Rasio Kapitalisasi marang Nilai Buku lexariabioscience.com|LEXX - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Lexaria Bioscience|LEXX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal lexariabioscience.com|LEXX - Gunggung utang perusahaan|Utang-utang marang aset resik Lexaria|LEXX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lexaria Bioscience|Rasio jangkoan perantara lexariabioscience.com
- data bathi lan kelipatan valuasi:
LEXX - Bathi resik|Bathi sing dikarepake Lexaria Bioscience|LEXX - Pangali P/E|Kapitalisasi marang proyeksi bathi lexariabioscience.com|LEXX - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Lexaria|LEXX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Lexaria Bioscience|LEXX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan lexariabioscience.com|LEXX - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lexaria Bioscience
- indikator pendapatan dodolan lan penghasilan bisnis:
LEXX - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan lexariabioscience.com|LEXX - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Lexaria
Analisis umum perusahaan:LEXX, Lexaria Bioscience Corp
Produk mawa merek Lexaria Bioscience Corp.

The P/S ratio determines the market value of a company relative to its annual sales volume. This metric compares market capitalization to revenue, allowing an investor to assess the premium paid per unit of income. By analyzing the price-to-sales ratio, one can detect market overheating of an asset in a timely manner. For Lexaria Bioscience (LEXX), such a valuation reflects market expectations regarding the commercialization of DehydraTECH technology within the drug delivery sector.

Perusahaan pesaing

HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue KVUE|Verona Pharma PLC - Rasio rega marang pendapatan|Jyong Biotech Corp - Multiplikator P/S|Rega marang dodolan Ligand Corp|AMRX (Amneal Pharmaceuticals) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan PRGO|ALVO (Alvotech SA) - Multiplikator P/S|Multiplikator P/S Liquidia Corp|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|ANIP (ANI Pharmaceuticals Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MNKD (MannKind Corporation)|Koefisien rega marang pendapatan amphastar.com (AMPH)|Pacira BioSciences, Inc. - Multiplikator P/S|SPRY - Multiplikator P/S|TBPH (Theravance) - Kapitalisasi marang pendapatan|Aquestive Corp - Rasio kapitalisasi pasar marang pendapatan|SCPH (scPharmaceuticals, Inc.) - Multiplikator P/S|Rasio rega marang pendapatan TECX|Multiplikator P/S TNXP|Koefisien rega marang pendapatan sxtchina.com|Rasio rega marang pendapatan Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rega marang dodolan|EXOZ - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Oramed Pharmaceuticals ORMP|ENTX: Multiplikator P/S|Kapitalisasi marang pendapatan MindWalk Holdings, Inc.|ABVC (ABVC BioPharma Inc) - Multiplikator P/S|Cumberland Corp (CPIX) - Koefisien rega marang pendapatan|Multiplikator P/S QNTM|FGEN - Rega marang dodolan|Rasio rega marang pendapatan Telomir Pharmaceuticals, Inc. TELO|RANI: Rasio kapitalisasi marang pendapatan|Synergy CHC Corporation - Multiplikator P/S|Rallybio Corporation (RLYB) - Kapitalisasi marang pendapatan|PULM: Multiplikator P/S|Rega marang dodolan Pheton Holdings (PTHL)|Rasio rega marang pendapatan Aptorum Group Ltd|Rasio rega marang pendapatan LYRA|Multiplikator P/S IBO|TNFA - Rega marang dodolan|cbdMD - Kapitalisasi marang pendapatan|PRFX: Rasio kapitalisasi marang pendapatan|CYTO: Kapitalisasi marang pendapatan|LIPO (Lipella Pharmaceuticals Inc) - Rasio kapitalisasi marang pendapatan|Optinose (OPTN) - Rasio rega marang pendapatan|Rasio rega marang dodolan PIRS (Pieris Pharma)|PROC (Procaps Group S.A.) - Multiplikator P/S|PTPI: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S QLI|Multiplikator P/S Acelyrin Inc. (SLRN)|Rasio rega marang pendapatan TFF Pharma TFFP